protein C inhibitor; plasma serine protease inhibitor; acrosomal serine protease inhibitor; plasminogen activator inhibitor 3; PAI-3; PAI3; PCI; Serpin A5 (SERPINA5, PCI, PLANH3, PROCI)
Jump to navigation
Jump to search
Function
- heparin-dependent serine protease inhibitor in body fluids & secretions
- inactivates serine proteases by binding irreversibly to their serine activation site
- role in regulation of intravascular & extravascular proteolysis
- hemostatic roles in the blood plasma
- acts as a procoagulant & proinflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin complex
- acts as an anticoagulant factor by inhibiting blood coagulation factors like prothrombin, factor XI, factor Xa, plasma kallikrein & fibrinolytic enzymes such as tissue-plasminogen activator & urinary-type plasminogen activators
- in seminal fluid, inactivates several serine proteases implicated in reproduction
- inhibits the serpin acrosin
- indirectly protects component of the male genital tract from being degraded by excessive released acrosin
- inhibits prostate-specific antigen & kallikrein
- regulates sperm motility & fertilization
- inhibits activated protein C-catalyzed degradation of SEMG1 & SEMG2
- regulates the degradation of semenogelin during transfer of spermatozoa from the male reproductive tract into the female tract
- inhibits the serpin acrosin
- in urine, inhibits urinary-type plasminogen activator & kallikrein
- inactivates membrane-anchored serine proteases activities such as MPRSS7 & TMPRSS11E
- inhibits urinary-type plasminogen activator-dependent tumor cell invasion & metastasis
- may also play a non-inhibitory role in seminal plasma & urine as an hydrophobic hormone carrier by its binding to retinoic acid
- inhibitory activity is greatly enhanced in the presence of glycosaminoglycans, heparin, thrombomodulin & phospholipids
- proteolytically cleaved
- inhibition of proteases is accompanied by formation of a stable enzyme-inhibitor complex & by degradation of the serpin to lower molecular weight derivatives
- proteolytically cleaved at the N-terminus
- forms protease inhibiting heterodimers in extracellular body fluids with serine proteases such as activated protein C/ coagulation factor V/F5, acrosin/ACR, chymotrypsinogen B/CTRB1, prothrombin/F2, factor Xa/F10, factor XI/F11, kallikrein/KLKB1, tissue kallikrein, trypsin/PRSS1, prostate specific antigen/KLK3, tissue plasminogen activator/PLAT & urinary plasminogen activator/PLAU
- forms protease inhibiting membrane-anchored heterodimers with TMPRSS7 & TMPRSS11E
- interacts with SEMG2
Structure
- N-glycosylated & O-glycosylated
- N-glycosylation consists of a mixture of sialylated bi- (including sialyl-Lewis X epitopes), tri- & tetra-antennary complex-type chains
- affects the maximal heparin- & thrombomodulin-enhanced rates of thrombin inhibition
- O- glycosylated with core 1 glycan or possibly core 8 glycan
- further modified with 2 sialic acid residues
- the reactive center loop (RCL) extends out from the body of the protein & directs binding to the target protease
- belongs to the serpin family
Compartment
- secreted, extracellular space
- localized on plasma membrane overlying acrosomal head of spermatozoa of ependymal spermatozoa & ejaculated sperm
- localized at the equatorial segment of acrosome-reacted spermatozoa
- localized in alpha granules in resting platelets & on the external plasma membrane & within the surface-connected cannalicular system in activated platelets
Expression
- predominantly expressed in epithelium of seminal vesicles
- expressed in the proximal tubular epithelium of the kidney
- expressed in the superficial & more differentiated epidermal keratinocytes of the skin
- expressed in megakaryocytes & platelets
- expressed poorly in kidney tumor cells compared to non tumor kidney tissues
- expressed in spermatozoa
- present in very high concentration in seminal plasma
- present in high concentration in plasma, synovial & Graaf follicle fluids
- present in low concentration in breast milk & in amniotic fluid
- present in very low concentration in urine, CSF, saliva & tears
- strongly expressed in liver
- expressed in kidney, spleen, pancreas, skeletal muscle, heart, testes, ovary, interstitial Leydig cells, epididimal glands, seminal vesicles & prostate
Notes
- relationship to tPA inhibitor unclear
More general terms
Additional terms
- protein C, activated
- protein C; vitamin K-dependent protein C; anticoagulant protein C; autoprothrombin IIA; blood coagulation factor XIV; contains: vitamin K-dependent protein C light chain; vitamin K-dependent protein C heavy chain; activation peptide (PROC)
References
- ↑ UniProt http://www.uniprot.org/uniprot/P05154.html
- ↑ SeattleSNPs http://pga.gs.washington.edu/data/serpina5/